DS-3939a targets TA-MUC1 on the cell surface, is internalized, and releases DXd, which inhibits DNA topoisomerase I to cause DNA damage and apoptosis. Topoisomerase I is the payload’s intracellular enzyme target, not the antigen that directs cell killing; only TA-MUC1–positive cells are selectively killed.